Van Ryn-McKenna J, Gray E, Weber E, Ofosu F A, Buchanan M R
Department of Pathology, McMaster University Medical Centre, Hamilton, Ontario, Canada.
Thromb Haemost. 1989 Feb 28;61(1):7-9.
To test the possibility that different doses of heparin or other sulfated polysaccharides are required to inhibit thrombosis initiated by different stimuli, we compared the effects of heparin (HEP), pentosan polysulfate (SP54) and dermatan sulfate (DS) on the inhibition of thrombus formation induced by either I) tissue thromboplastin; II) thrombin; or III) factor Xa. Inhibition of thrombus formation induced by the stimuli was measured in a rabbit jugular vein hypercoagulation/stasis model. First, we determined the minimum dose of each sulfated polysaccharide which inhibited tissue thromboplastin-induced thrombus formation by approximately 75%, and then compared the relative effectiveness of this dose to prevent thrombus formation initiated with the other two stimuli. HEP and SP54 were less effective when thrombin was the thrombogenic stimulus, while DS was more effective. HEP was the most effective agent when factor Xa was the stimulus. We conclude that the antithrombotic effectiveness of a given dose of a sulfated polysaccharide may vary depending on the stimulus which initiates thrombus formation.
为了测试是否需要不同剂量的肝素或其他硫酸化多糖来抑制由不同刺激引发的血栓形成,我们比较了肝素(HEP)、戊聚糖多硫酸盐(SP54)和硫酸皮肤素(DS)对以下三种刺激诱导的血栓形成抑制作用:I)组织凝血活酶;II)凝血酶;或III)Xa因子。在兔颈静脉高凝/淤滞模型中测量刺激诱导的血栓形成抑制情况。首先,我们确定了每种硫酸化多糖抑制组织凝血活酶诱导的血栓形成约75%的最小剂量,然后比较该剂量预防由其他两种刺激引发的血栓形成的相对有效性。当凝血酶作为血栓形成刺激物时,HEP和SP54的效果较差,而DS更有效。当Xa因子作为刺激物时,HEP是最有效的药物。我们得出结论,给定剂量的硫酸化多糖的抗血栓形成效果可能因引发血栓形成的刺激不同而有所差异。